Clinical Trial Update: A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CNTO 1959 in adults with moderate to severe plaque-type psoriasis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CNTO 1959

Snippet

Sponsor: Janssen Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-08-02